Splenomegaly Summary

Networked: 2980 relevant articles (187 outcomes, 149 trials/studies) for this Disease

Key Drugs and Agents for Splenomegaly

1. INCB018424 : 24 outcomes 25 studies in 70 results : IBA
   
2. Iron : 8 outcomes 3 studies in 51 results : IBA
   
3. Hemoglobins (Hemoglobin) : 8 outcomes 2 studies in 120 results : IBA
   
4. Phosphotransferases (Kinase) : 6 outcomes 6 studies in 14 results : IBA
   
5. Hydroxyurea (Hydrea) : 4 outcomes 2 studies in 18 results : FDA 6 Generic
   
6. Carbon Monoxide : 4 outcomes in 27 results : IBA
   
7. Cytokines : 4 outcomes in 21 results : IBA
   
8. Immunoglobulin G (IgG) : 3 outcomes 4 studies in 85 results : IBA
   
9. Praziquantel (Biltricide) : 3 outcomes 2 studies in 7 results : FDA 1
   
10. Interferon-alpha (Interferon Alfa) : 3 outcomes 1 study in 15 results : FDA 2
    

Diseases Related to Splenomegaly

1. Primary Myelofibrosis (Myelosclerosis)
2. Lymphatic Diseases (Lymphadenopathy)
3. Infection
4. Fibrosis (Cirrhosis)
5. Anemia

Key Therapies for Splenomegaly

1. Splenectomy : 42 outcomes 35 studies in 573 results
   
2. Drug Therapy (Chemotherapy) : 6 outcomes 1 study in 88 results
   
3. Aftercare (After-Treatment) : 4 outcomes in 17 results
   
4. Ligation : 3 outcomes 1 study in 16 results
   
5. Palliative Care (Palliative Medicine) : 3 outcomes 1 study in 6 results